Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors

被引:0
作者
I. Gueta
R. Loebstein
N. Markovits
Y. Kamari
H. Halkin
G. Livni
H. Yarden-Bilavsky
机构
[1] Sheba Medical Center,Institute of Clinical Pharmacology and Toxicology
[2] Tel Aviv University,Sackler School of Medicine
[3] Sheba Medical Center,The Bert Strassburger Lipid Center
[4] Schneider Children’s Medical Center,Department of Pediatrics A
来源
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词
Voriconazole; QT prolongation; Adverse effects; Torsade de pointes; Safety;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1181 / 1185
页数:4
相关论文
共 59 条
  • [1] Walsh TJ(2008)Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 327-360
  • [2] Anaissie EJ(2004)Adverse reactions to voriconazole Clin Infect Dis 39 1241-1244
  • [3] Denning DW(2015)Phototoxicity, pseudoporphyria and photo-onycholysis due to voriconazole in a pediatric patient with leukemia and invasive aspergillosis J pediatric Infect Dis Soc 4 e22-e24
  • [4] Boyd AE(2004)Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect Clin Infect Dis 39 e49-e52
  • [5] Modi S(2011)Voriconazole-induced QT interval prolongation and torsades de pointes Pediatr Int 53 761-763
  • [6] Howard SJ(2007)Torsades de pointes associated with voriconazole use Transpl Infect Dis 9 33-36
  • [7] Moore CB(2012)QTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy Eur Rev Med Pharmacol Sci 16 100-102
  • [8] Keevil BG(2014)Voriconazole associated torsades de pointes in two adult patients with haematological malignancies Med Mycol Case Rep 13 23-25
  • [9] Denning DW(2013)Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients Antimicrob Agents Chemother 57 1121-1127
  • [10] Willis ZI(2013)Drug-induced arrhythmia: pharmacogenomic prescribing? Eur Heart J 34 89-95